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During cellular DNA replication the lagging strand is
generated as discontinuous segments called Okazaki
fragments. Each contains an initiator RNA primer that
is removed prior to joining of the strands. Primer re-
moval in eukaryotes requires displacement of the
primer into a flap that is cleaved off by flap endonucle-
ase 1 (FEN1). FEN1 employs a unique tracking mecha-
nism that requires the recognition of the free 5 termi-
nus and then movement to the base of the flap for
cleavage. Abnormally long flaps are coated by replica-
tion protein A (RPA), inhibiting FEN1 cleavage. A sec-
ond nuclease, Dna2p, is needed to cleave an RPA-coated
flap producing a short RPA-free flap, favored by FEN1.
Here we show that Dna2p is also a tracking protein.
Annealed primers or conjugated biotin-streptavidin
complex block Dna2p entry and movement. Single-
stranded binding protein-coated flaps inhibit Dna2p
cleavage. Like FEN1, Dna2p can track over substrates
with a non-Watson Crick base, such as a biotin, or a miss-
ing base within a chain. Unlike FEN1, Dna2p shows evi-
dence of a “threading-like” mechanism that does not sup-
port tracking over a branched substrate. We propose that
the two nucleases both track, Dna2p first and then FEN1,
to remove initiator RNA via long flap intermediates.
During cellular DNA replication, the lagging strand is
primed frequently to generate many RNA-initiated DNA seg-
ments called Okazaki fragments. In eukaryotes, these seg-
ments are 100–150 nucleotides in length (1–3). The 8–12 ribo-
nucleotide primers (4) must be removed prior to joining of the
DNA segments to make the continuous lagging strand. The
primer is cleaved off via a single-stranded flap intermediate, a
structure that increases the accessibility of the primers to
nucleases. The flap is created by the strand displacement syn-
thesis activity of DNA polymerase  and proliferating cell nu-
clear antigen (5–7).
Two nucleases that have been proposed to access and cleave
flaps (6, 8–10). One is flap endonuclease 1 (FEN1).1 FEN1 is a
structure-specific endonuclease that recognizes one intermedi-
ate of strand displacement. This is a double flap with a 1-nu-
cleotide 3-tail (11–13).
Biochemical analyses showed that FEN1 employs a unique
tracking mechanism in which it recognizes the free 5-end of
the flap and then moves to the base of the flap for cleavage (14).
Crystal structures of FEN1 and its homologues reveal a con-
served flexible region, called the helical arch or loop domain,
through which the flap was proposed to be threaded during
tracking (15–18). The term “threading” is taken to mean that
the flap passes through a fully enclosed hole in the protein.
However, studies of substrate specificity indicated that the
enzyme is able to cleave on a branched substrate that could not
fit through the proposed hole (19). This indicates that FEN1
tracking does not employ a threading mechanism. The obliga-
tory nature of tracking suggests that it is important for the
protection of replication intermediates.
Studies of enzyme properties and reconstituted assays indi-
cate that FEN1 prefers short flap substrates and that coordi-
nated strand displacement and cleavage result in frequent cuts
(6, 10). These results suggest that within the cell, flaps are
removed when they are only a few nucleotides long. However,
in some regions, stable structures can form within the flap as
soon as the flaps arise, inhibiting the accessibility of the sub-
strates to FEN1. These structures will inhibit FEN1 cleavage
and allow the flap to get longer than normal (10, 20). In this
situation, flaps may get long enough for RPA coating, which
inhibits FEN1 tracking for cleavage. These flaps are proposed
to require another protein for efficient metabolism, the Dna2
helicase/nuclease (10, 21).
Dna2p is a multifunctional enzyme that possesses 5–3
helicase, DNA-specific ATPase, and single strand DNA-specific
endonuclease activities (22). Dna2p is an essential gene in
yeast, encoding a 172-kDa protein (9, 23, 24). Genetic analyses
indicated that FEN1 and Dna2p interact with each other both
physically and genetically, suggesting the two enzymes work at
a similar step of DNA replication (9). In addition, Dna2p inter-
acts with RPA biochemically and genetically, suggesting a
model in which Dna2p and RPA process long flaps to produce
short flaps that support cleavage by FEN1 (6, 10, 21). Because
both Dna2p and FEN1 act on flap intermediates during repli-
cation, and a preference of both helicase and endonuclease
activities of Dna2p for 5-ends was reported (22, 25), we ques-
tioned whether Dna2p has evolved to track on flaps like FEN1.
Preliminary biochemical analyses indicated that Dna2p en-
donuclease activity prefers ssDNA as the point of entry, but the
enzymatic activity is higher when a 5-end rather than a 3-end
is available (22). Cleavage of single-stranded DNAwith no ends
could occur (22, 23, 26), but it was inhibited by RPA (22).
Nuclease activity of Dna2p is maximal under conditions in
which Mg2 is high and ATP is low or absent, and the helicase
activity is best observed when nuclease activity is lowered by
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the presence of high ATP and lower Mg2. One or the other of
the two functional activities can be observed preferentially by
changing the balance of ATP and Mg2 (10, 23, 25). Unwinding
assays show that Dna2p utilizes the 5-end of single-stranded
DNA as an efficient entry point, and this activity is increased
as the tail length increases up to 25 nucleotides (25). It was
suggested that 3-nuclease is not relevant for Dna2p because
ATP and RPA inhibit this activity (10, 22). Although Dna2p
could also bind from the internal single-stranded region prior
to displacing the primer segment, this activity is weak and dis-
tributive (25). Generally helicases do not exhibit an end prefer-
ence for substrate binding because a substrate flanked by differ-
ence lengths of primers at either end of a template could be
utilized to determine the polarity of virtually all the helicases
(27). By this criterion, Dna2p is a unique helicase/nuclease (25).
Despite several reports on Dna2p substrate specificity, the
mechanism behind the free end preference remains unan-
swered. We wanted to know the events that occur when Dna2p
encounters a flap substrate. We speculated that Dna2p em-
ploys a FEN1-like tracking mechanism, because both enzymes
share a similar pathway in replication. To test this hypothesis,
we utilized substrates capable of defining specific characteris-
tics of the tracking process. Our observations in vitro reveal
that Dna2p does indeed track on flap substrates. They suggest
that this unique mechanism is used to protect against internal
cleavage of replication intermediates during Okazaki fragment
processing.
EXPERIMENTAL PROCEDURES
Materials—Oligonucleotides were synthesized by Integrated DNA
Technologies (Coralville, IA). Radionucleotides [-32P]ATP (6000 Ci/
mmol) and [-32P]dCTP (6000 Ci/mmol) were from PerkinElmer Life
Sciences. The T4 polynucleotide kinase (labeling grade), the Klenow
fragment of DNA polymerase I, and ATP were from Roche Applied
Science. Nuclease-free solutions and reagents were from Ambion, Inc.
(Austin, TX). All other reagents were the best available commercial
grade.
Enzyme Expression and Purification—Saccharomyces cerevisiae
Dna2p was cloned into the Sf9 baculovirus expression vector (Invitro-
gen). The amplification/expression and purification conditions were the
same as described previously (23), except that High Five cells were
utilized for the final expression step of the protein. S. cerevisiae FEN1
was expressed in Escherichia coli, and it was subsequently purified
under the same conditions described elsewhere (13). S. cerevisiae RPA
was expressed and purified according to Sibenaller et al. (28), except
that the Mono-Q column was omitted.
Oligonucleotide Substrates—Oligomer sequences are listed in Table
I. Oligomers were annealed as described in the figure legends to form
various structures. Modifications to create the branched and amino
substrates were as described previously (19). The biotinylated sub-
strates were synthesized by Integrated DNA Technologies (Coralville,
IA), and the locations of the biotinylation are indicated as underlined
nucleotides in the table. Annealing and labeling conditions were the
same as described previously (29), except that the annealing ratio is
1:4:8 (downstream:template:upstream) and 1:2:4 for the reactions con-
taining single-stranded binding protein (SSB) and RPA. Blocking prim-
ers were present in 10-fold excess over the annealed flap substrates. All
radiolabeled primers were purified by gel isolation from 12 or 15%
polyacrylamide, 7 M urea denaturing gels. The 10-nucleotide markers
were obtained by 5-labeling the 10-bp markers from Invitrogen using
[-32P]ATP (6000 Ci/mmol) (PerkinElmer Life Sciences), and they were
heat-denatured prior to loading of the gel.
Enzyme Assays—Reactions were performed in 50 mM Tris-HCl (pH
8.0), 2 mM dithiothreitol, 0.25 mg/ml bovine serum albumin, 30 mM
NaCl, and various ratios of MgCl2 and ATP. Enzyme stocks were
diluted in 50 mM Tris-HCl (pH 8.0), 2 mM dithiothreitol, 0.5 mg/ml
TABLE I
Oligonucleotide sequences (5–3)
Downstream primersa,b
D1 (60-mer) TCGCACGTTTCACGCCTGTTACTTAATTCACTGGCCGTCGTTTTACAACGACGTGACTGG
D2 (43-mer) CGTACGGACGTAGAGCTGTTTCCAAGTAAAACGACGGCCAGTG
D3 (96-mer) CGACTCTAGAGGATCCCCGGGTACCGAGCTCGAATTCGCCCGTTTCACGCCTGTTAGTTAATTCACTGGCCGT
CGTTTTACAACGACGTGACTGGG
D4 (76-mer) GTACCGAGCTCGAATTCGCCCGTTTCACGCCTGTTAGTTAATTCACTGGCCGTCGTTTTACAACGACGTGACTGGG
D5 (100-mer) GACTCTCGACTCACGTAGAGCTGTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTCCAAGTA
AAACGACGGCCAGTGCTACGAG
D6 (58-mer) TCGCXCGTTTCACGCCTGTTACTTAATTCACTGGCCGTCGTTTTACAACGTGACTGGG
D7 (55-mer) AGGTCTCGACTAACTCTAGTCGTTGTTCCACCCGTCCACCCGACGCCACCTCCTG
D8 (25-mer) CGACCGTGCCAGCCTAAATTTCAAT
D9 (20-mer) GACGAATTCCGGATACGACG
Upstream primers
U1 (26-mer) CGCCAGGGTTTTCCCAGTCACGACCA
U2 (25-mer) CGCCAGGGTTTTCCCAGTCACGACC
U3 (26-mer) CGACCGTGCCAGCCTAAATTTCAATA
U4 (18-mer) CCACCCGTCCACCCGACG
U5 (20-mer) TGCTGGGATCCTACAACCAA
Templates
T1 (48-mer) GCCAGTCACGTCGTTGTAAAACGGGTCGTGACTGGGAAAACCCTGGCG
T2 (44-mer) GCACTGGCCGTCGTTTTACGGTCGTGACTGGGAAAACCCTGGCG
T3 (49-mer) GCCCAGTCACGTCGTTGTAAAACGGGTCGTGACTGGGAAAACCCTGGCG
T4 (76-mer) GCTCGTAGCACTGGCCGTCGTTTTACGGTCGTGACTGGGAAAACCCTGGCGAACAGCTCTACGTGAGTCGA
GAGTC
T5 (46-mer) GCCCAGTCACGTTGTAAAACGGGTCGTGACTGGGAAAACCCTGGCG
T6 (51-mer) GCAGGAGGTGGCGTCGGGTGGACGGGATTGAAATTTAGGCTGGCACGGTCG
T7 (72-mer) ATTGAAATTTAGGCTGGCACGGTCGGCACTGGCCGTCGTATCCGCAGGAGGTGGCGTCGGGTGGACGGGTGG
T8 (110-mer) TTGGTTGTAGGATCCCAGCACATTGAAGGCAGGAGGTGGCGTCGGGTGGACGGGTGGATTGAAATTTAGGC
TGGCACGGTCGGCACTGGCCGTCGTATCCGGAATTCGTC
Blocking primers
B1 (18-mer) CAGCTCTACGTCCGTACG
B2 (20-mer) CCGGGGATCCTCTAGAGTCG
B3 (21-mer) GGGCGAATTCGAGCTCGGTAC
B4 (23-mer) ACGGCCAGTGAATTAACTAACAG
a The boldface nucleotides represent the location of modification. D6 contains either guanosine or 3-amino-thiocyano-1,2-propanediol at position
X. D1 contains DNA side chains.
b The underlined nucleotide indicates a biotin modification.
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bovine serum albumin, 10% glycerol, 0.5 M NaCl, and 0.02% Nonidet
P-40. The “maximum-nuclease” assays include excess MgCl2 over ATP
(2 mM MgCl2 and 1 mM ATP), whereas the “maximum-helicase” assays
contain excess ATP over MgCl2 (1 mM MgCl2 and 2 mM ATP). Most
assays were performed under one of these conditions. Each reaction
contains 5-fmol substrates in a 20-l reaction volume with different
amounts of the enzymes as indicated in the figure legends. All the
assays were preincubated at 37 °C for 5 min (maximum-helicase con-
ditions with substrates, enzyme, and ATP or maximum-nuclease con-
ditions with substrates and enzymes). The reactions were initiated at
37 °C for 10 min with the addition of MgCl2 (for maximum-nuclease
conditions, ATP was added with MgCl2 at the end of the preincubation
time). Reactions were then stopped by the addition of 20 l of 2
termination dye (95% formamide (v/v) with bromphenol blue and xylene
cyanole). The denatured reactions were resolved on 12 or 15% polyacryl-
amide, 7 M urea denaturing gels. Each gel was quantitated using a
PhosphorImager (Amersham Biosciences) and analyzed using Image-
Quant version 1.2 software from Amersham Biosciences. In all studies,
the quantitated amount of substrates and products were utilized to
calculate the percentage of product formation from the product/(sub-
strate plus product) ratio. The % product formation is indicated below
each gel in the figures. This method allows for the correction of any
loading errors among lanes. All assays were performed at least in
triplicate, and representative assays are shown.
RESULTS
To dissect out the multiple activities of Dna2p, we employed
previously developed reaction conditions. One favors maxi-
mum-nuclease (MgCl2  ATP) in which high MgCl2 supports
nuclease activity, masking the helicase activity by cutting the
flap substrate. The other favors maximum-helicase (ATP 
MgCl2 and with a 5-min preincubation of the enzyme and
substrate) in which excess ATP sequesters free MgCl2 reducing
the nuclease activity and allowing helicase to interact with the
substrates (10). By controlling these conditions, we can exam-
ine the cleavage properties of Dna2p nuclease and the influence
of the helicase activity on Dna2p nuclease on different sub-
strates. These conditions also allow us to monitor the tracking
mechanism in the presence and absence of helicase activity
with the wild-type protein.
Dna2p Makes Multiple Cuts on a Long Flap—It was shown
previously that Dna2p possesses a weak, distributive helicase
activity. This is able to influence the positions of cleavage
under maximum-helicase conditions, with a flap that is 27
nucleotides or longer (10, 22, 26). We first examined the pat-
terns of nuclease cleavage under nuclease versus helicase con-
ditions. Specifically we wanted to know whether Dna2p cleaves
a long flap in a progressive fashion by making a series of cuts
that shorten the flap in a stepwise manner. To accomplish this,
we employed 38-nucleotide flap substrates labeled at either the
3- or 5-end of the downstream primer (Fig. 1). Fig. 1, lanes 1–7
and 8–14, shows cleavages of the 5-radiolabeled and 3-radio-
labeled substrates, respectively, compared under both condi-
tions. 5-Radiolabeled substrates show that longer cleavage
products are released under maximum-helicase conditions
(Fig. 1, compare lanes 2–4 to 5–7), similar to what was observed
previously (10, 22). This indicates that Dna2p progresses fur-
ther toward the flap junction before allowing the first cleavage
or that inhibiting the nuclease allows further translocation
before cleavage. This is also consistent with the earlier report
that the nuclease product is longer in the presence of ATP (30).
However, most initial cleavages are not close to the base of the
flap (38 nucleotides from the 5-labeled end) under either con-
dition. The downstream duplex was not unwound at all, con-
sistent with other observations that the helicase activity is
weak (10, 26).
Examination of the 3-substrates (Fig. 1, lanes 8–14) shows
that majority of the products represent cleavages near the base
of the flap. Because the products from the 3-substrates reflect
the sum of all cleavage events occurring on one substrate, the
fact that these are distributed closer to the flap base under both
conditions implies that each substrate sustained multiple pro-
gressive cuts by the nuclease. These results show progression
but do not define whether the cleavage process is processive,
i.e. carried out by the same protein. Several Dna2p proteins
may collaborate to reduce the flap length.
Dna2p Cleavage Requires a Free 5 Terminus—Dna2p was
found to prefer free 5-ends (10, 22, 25), and primers annealed
to a free ssDNA and biotin-strepavidin conjugation can de-
crease Dna2p nuclease activity (22). We asked whether the end
preference was influenced by the helicase function because the
helicase had been reported to allow Dna2p to load internally,
and Dna2p was shown to cleave some substrates in which end
loading was not possible (23, 25, 26). We tested substrates that
contain a downstream primer with a 25-nucleotide flap (Fig.
2A). On one substrate a 17-nucleotide primer was annealed at
the 5-end of the flap (Fig. 2A, lanes 8–14). Under both maxi-
mal-nuclease and maximal-helicase conditions, Dna2p was
able to cleave the 25-nucleotide flap (Fig. 2A, lanes 1–7). How-
FIG. 1. Dna2p makes multiple cuts on a flap. A Dna2p titration
assay (0, 10, 50, and 100 fmol, as indicated by the triangles) under
either maximum-nuclease or maximum-helicase conditions was em-
ployed. The experimental conditions and the labeling protocols were the
same as described under “Experimental Procedures.” An extra nucleo-
tide at the 3-end of the template is purposely designed in all substrates,
creating a one-nucleotide overhang, that allows 3-nucleotide addition
by Klenow fragment. Both substrates tested are in 38-nucleotide nicked
double flap configuration and contain exact sequences (D1:T1:U1). The
only difference in these substrates is that one is 5-32P-radiolabeled and
the other is 3-32P-radiolabeled, in lanes 1–7 and lanes 8–14, respec-
tively. The numbers of nucleotides on the flap and numbers of base
pairs on the duplex regions are indicated. The 3-labeled substrate
contains one more nucleotide in the downstream annealed duplex,
creating a blunt end (23 nucleotides annealed on the downstream
duplex), because of the addition of the radioactive dC. In the 5-labeled
substrate, the one-nucleotide overhang is represented as a staggered
end in the schematic diagram. Lanes 1 and 8 are the substrate-only
controls. Lanes 2–4 and 9–11 are under maximum-nuclease conditions,
whereas lanes 5–7 and 12–14 are under maximum-helicase conditions.
Schematic representations of the substrate structures are depicted on
the top of the gel, and a nucleotide length marker series is indicated at
the left side of the gel. Percent product formation, defined as “(product/
(product starting substrates)) 100,” is indicated at the bottom of the
gel. N, maximum-nuclease; H, maximum-helicase.
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ever, the presence of the 17-nucleotide terminal duplex pre-
vented cleavage within the 8-nucletoide gap (Fig. 2A, lanes
8–14). The helicase activity moves the Dna2p on these sub-
strates because we see cleavage closer to the flap base under
helicase conditions (Fig. 2A, compare lanes 2–4 to 5–7). How-
ever, the presence of ATP in excess over MgCl2 and helicase
FIG. 2.Dna2p cleavage requires a free 5-end of a DNA. A Dna2p titration assay (0, 10, 50, and 100 fmol, as indicated by the triangles) under
either maximum-nuclease or maximum-helicase conditions was employed in both A and B. The assay conditions were the same as described under
“Experimental Procedures.” A, Dna2p cleavage is blocked by primers annealed to the 5 terminus of a flap substrate. Lanes 1–7 contain
3-radiolabeled 25-nucleotide double flap substrates (D2:T2:U1) as the no-blocking-primer controls. Lanes 8–14 contain blocking primers B1. Lanes
1 and 8 are the substrate-only controls. Lanes 2–4 and 9–11 are under maximum-nuclease conditions, whereas lanes 5–7 and 12–14 are under
maximum-helicase conditions. Schematic representations of the substrate structures are depicted on the top of the gel. The numbers of the
nucleotides in the flap and the numbers of base pairs in the duplex regions are labeled. Percent product formation is indicated at the bottom of the
gel. A 10-nucleotide length marker series is indicated at the left side of the gel. B, bubble substrates inhibit Dna2p cleavage. The experimental
design is the same as in A, but a 53-nucleotide double flap (D4:T3:U1), 50-nucleotide bubble (D5:T4), nick-bubble (D5:T4:U2), and double flap-bubble
(D5:T4:U1) substrates were utilized, respectively, in lanes 1–7, 8–14, 15–21, and 22–28. N, maximum-nuclease; H, maximum-helicase.
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function does not allow the bypass of the 5-end requirement for
Dna2p loading onto a substrate. A larger gap between the
blocking primer and the flap base (53 nucleotides) also shows
similar results as described below (Fig. 3A), ruling out the
possibility that the eight nucleotides is too short for effective
Dna2p binding. Apparently 5-end loading is also a require-
ment for cleavage on these substrates even when the helicase is
maximally active (Fig. 3A, compare lanes 5–7 to 12–14).
A bubble substrate is defined as having the 5-end of the flap
annealed to the template. Such substrates resist FEN1 cleav-
age because of its 5-end requirement (20, 29). The bubble
structure creates a particularly convincing substrate for test-
ing the requirement for a 5-end. Primers annealed to flaps
allow some FEN1 access presumably because annealing is not
100% efficient (data not shown). However, the two-site anneal-
ing of the bubble primer appears to make it a stable configu-
ration. Bubble substrates were tested with Dna2p (Fig. 2B).
Alternative structures were created that simulate Okazaki
fragment intermediates either with no upstream primer, a
fully annealed upstream primer, or an upstream primer that
forms a double flap. In all three cases the single-stranded
bubble region is long enough to ensure space for enzyme bind-
ing (50 nucleotides). Even though a 53-nucleotide control flap
substrate sustained expected cleavages under both conditions
(Fig. 2B, lanes 1–7), Dna2p failed to cleave any of the bubble
structures (lanes 8–28), supporting an absolute requirement
for Dna2p to load at a 5-end. This result is fully consistent
with the blocking effect of a primer annealed on the flap and
indicates that Dna2p is not designed for internal access to
single-stranded DNA.
Dna2p Cleavage Employs a Tracking Mechanism—The 5-
end requirement is consistent with two alternative mecha-
nisms. One is a tracking mechanism in which the enzyme
enters from the 5-end and then traverses the single-stranded
region to the point of cleavage. The other is a looping mecha-
nism. In this scenario, binding to the 5-end of the flap acti-
vates the enzyme for subsequent functions. It is then able to
bind the single-stranded region for movement or cleavage by
looping the flap so that the 5-end is near the site of cleavage.
During this process the enzyme is bound at two sites on the
flap. To delineate these two mechanisms, we first employed
substrates that were used to define the tracking mechanism of
FEN1 (14) (Fig. 3). A 73-nucleotide flap substrate was con-
structed, and an oligomer was annealed to the flap at its 5-end,
in the middle, or at its base (Fig. 3A). We reasoned that if
Dna2p employs a looping mechanism, the substrate with the
primer in the middle of the flap would be cleaved in the 32-
nucleotide gap region between the primer and the flap base.
This is because the Dna2p can access both the 5-end and a
cleavable internal region. The control substrate was cleaved
well by Dna2p under both conditions (Fig. 3A, lanes 1–7). As
expected, the 5-terminal blocking primer inhibited Dna2p
cleavage (Fig. 3A, lanes 8–14). We note that the 53-nucleotide
region provides a large area of access with a variety of se-
quences and structures, and yet virtually no cleavage is seen
(Fig. 3A, lanes 8–14). With the flap containing a primer in the
middle (Fig. 3A, lanes 15–21), the 32-nucleotide gap is not
cleaved. Instead, substantial cleavage is observed in the 20-
nucleotide region between the 5-end and the primer. This
result argues against the looping mechanism. It indicates that
Dna2p loads onto the 5-end and tracks to the point where it is
blocked by the primer. Results with the primer placed at the
flap base reinforce this conclusion (Fig. 3A, lanes 22–28). In
that case, Dna2p appears to track the further distance to the
primer, cleaving throughout the single-stranded region. Effec-
tive blockage by the primer is consistent with the notion that
Dna2p possesses a weak helicase activity, incapable of displac-
ing a 23-nucleotide primer (10, 23, 25, 26). Note that Dna2p
cleaves right up to the site of the block (Fig. 3A), whereas it
only gets to within 5–7 nucleotides of the flap junction on other
substrates. Perhaps the fork structure sterically hinders fur-
ther cleavages closer to the flap junctions.
In another approach to distinguish a tracking from a looping
mechanism, we placed biotin modifications either at the 5-end
or in the middle of 53-nucleotide flaps (Fig. 3B). The unmodi-
fied flaps are cleaved equally well by Dna2p in the absence or
presence of streptavidin (Fig. 3B, lanes 1–6), indicating that
unbound streptavidin does not interfere with Dna2p catalysis.
A substrate biotinylated at the 5-end is cleaved by Dna2p in
the absence of streptavidin (Fig. 3B, lanes 7–9), implying that
the biotin modification does not inhibit the recognition of the 5
terminus of DNA, a result obtained previously (22). Conjuga-
tion of streptavidin to the biotinylated substrate inhibits cleav-
age (Fig. 3B, lanes 10–12), presumably by blocking the entry of
Dna2p. This is consistent with the results obtained from the
blocking primers used above. When streptavidin is conjugated
to a biotin in the middle of the flap (Fig. 3B, lanes 16–18),
cleavage occurs prior to the conjugation site but not beyond it.
In principle, this substrate is similar to the substrate with a
primer in the middle of the flap. In fact, the biotin-streptavidin
flap should be even more flexible than the primed flap to allow
for looping. The absence of cleavage beyond the conjugation site
is additional evidence that the 5-end is an entry site for track-
ing and not an activation site for looping. This result also
verifies that the helicase function of Dna2p cannot force the
dissociation of the streptavidin.
Dna2p Can Track Over Alternative Structures and Does Not
Require Contact with a Continuous Series of Nucleotides—
Because cleavages by Dna2p occur on biotinylated flaps in the
absence of streptavidin (Fig. 3B, lanes 13–15), Dna2p must be
able to track over a bulky adduct on DNA. This suggests that
tracking does not require Dna2p contact with a series of un-
modified nucleotides. To assess further the nucleotide struc-
ture requirement of the flap for tracking, we tested a flap in
which two adjacent nucleotides were separated by a 3-amino-
thiocyano-1,2-propanediol (19) (Fig. 4A). Both the unmodified
(Fig. 4A, lanes 1–7) and modified substrates (lanes 8–14) were
examined under both maximum-nuclease and maximum-heli-
case conditions. Dna2p was similarly capable of tracking and
cleaving both substrates. This suggests that similar to FEN1,
the tracking of Dna2p does not require the contact of a perfect
series of natural nucleotide structures on the flap.
The Mechanism Appears to Involve Threading—As discussed
above, the tracking mechanism of FEN1 is very forgiving of
large structures on the flap including polymer branches (19),
indicating that the flap is not threaded through a hole in the
protein. To consider this same issue with Dna2p, we employed
a substrate with a branched flap (19) (Fig. 4B). The substrate
has a 38-nucleotide flap. The 27th residue from the base of the
flap is a ribonucleotide with an 11-nucleotide branch attached
at the 2-position. The branch is attached at its 3-end and has
a native free 5-end. When the unbranched control substrate
was tested under both conditions, it was readily cleaved by
Dna2p (Fig. 4B, lanes 3–8). It was also susceptible to FEN1
(Fig. 4B, lane 2). The branched substrate was also effectively
cleaved by FEN1 (Fig. 4B, lane 10), which evidently tracks over
the branch point. However, the cleavage pattern for Dna2p
(Fig. 4B, lanes 11–16) suggests tracking from one or the other
5-end only up to the branch point. Cleavages were present
from the 5-end to the branch point. No cleavages were ob-
served after the branched point, suggesting that Dna2p exhib-
its a “threading-like” mechanism. Presumably, the hole or cleft
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FIG. 3. Cleavage by Dna2p requires a tracking mechanism. A, Dna2p titration assay (0, 10, 50, and 100 fmol, as indicated by the triangles)
under either maximum-nuclease or maximum-helicase conditions was employed. The assay conditions were the same as described under
“Experimental Procedures.” Lanes 1–7 contain 3-radiolabeled 73-nucleotide double flap substrates (D3:T3:U1) and a poly(dT)16 primer, a
non-complementary primer, as the no-blocking primer control. Lanes 8–14, 15–21, and 22–28 contain blocking primers B1, B2, and B3, respectively,
that are annealed at distances leaving a gap of 53, 32, and 0 nucleotides from the first annealed nucleotide on the downstream duplex DNA. Lanes
1, 8, 15, and 22 are the substrate-only controls. Lanes 2–4, 9–11, 16–18, and 23–25 are under maximum-nuclease conditions, whereas lanes 5–7,
12–14, 19–21, and 26–28 are under maximum-helicase conditions. Schematic representations of the substrate structures are depicted on the top
of the gel. For A and B, the numbers of nucleotides in the flap and numbers of the base pairs in the duplex regions are labeled. Percent product
formation is indicated at the bottom of the gel. A 10-nucleotide length marker series is indicated at the left side of the gel. B, a single amount of
Dna2p (50 fmol) was utilized in each reaction. Substrates (5 fmol) were preincubated with and without 25-fold excess of streptavidin for 5 min at
37 °C and followed by either maximum-nuclease (lanes 2, 5, 8, 11, 14, and 17) or maximum-helicase (lanes 3, 6, 9, 12, 15, and 18) conditions as
described under the “Experimental Procedures.” Lanes 1–6 contain the non-biotinylated substrate control (D4:T3:U1). Lanes 7–12 and 13–18 include
substrates (D4:T3:U1) that are biotinylated at the 1st or the 25th nucleotide from the 5-end of the flap, respectively. The experimental setup and
the schematic representation of the substrates are indicated at the top of the gel, and a 10-nucleotide length marker series is indicated at the left
side of the gel. N, maximum-nuclease; H, maximum-helicase.
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in the protein that allows passage of the single-stranded DNA
is too small of a diameter to allow entry of the branch point.
Proteins Bound to the Flap Inhibit Dna2p Tracking and
Cleavage—Because Dna2p tracks similarly to FEN1, we antic-
ipated that as with FEN1 (14), most proteins bound to the flap
would also inhibit the tracking and cleavage by Dna2p. We
tested prokaryotic SSB and also yeast RPA (data not shown). It
was reported that RPA interacts with Dna2p biochemically and
genetically (21). This interaction is a specific protein-protein
contact that stimulates the activity of Dna2p (21, 31). We
hypothesized that except for the RPA-bound flaps, which coor-
dinate the two nucleases in processing abnormally long flaps
during Okazaki fragment processing (10, 21), any other pro-
teins bound to the DNA such as SSB will block Dna2p activity.
When we tested 53-nucleotide flap substrates in the presence of
SSB and RPA, we observed the stimulatory effects of RPA on
Dna2p under both conditions, but SSB inhibited the Dna2p ac-
tivity. The result is similar to a previous report that RPA stim-
ulates Dna2p on a 5-overhang substrate and SSB inhibits
Dna2p on that structure (21). This indicates that proteins bound
to the flap will block the tracking mechanism of Dna2p and affect
its cleavage activity, as observed with FEN1 (10, 14, 21). The
process by which RPA stimulates Dna2p without blocking its
entry onto the flap substrate needs to be further examined.
FIG. 4. Dna2p can track over modi-
fied sites, and a threading-like mech-
anism may be involved. Dna2p titra-
tion assay (0, 10, 50, and 100 fmol, as
indicated by the triangles) under either
maximum-nuclease or maximum-helicase
conditions was employed in both A and B.
The experimental conditions and the la-
beling protocols were the same as de-
scribed under “Experimental Proce-
dures.” A, the substrates utilized were 3-
32P-radiolabeled 38-nucleotide double
flaps (D6:T5:U1) in lanes 1–7 and 3-amino-
thiocyano-1,2-propanediol modified flap
substrates in lanes 8–14. Lanes 1 and 8
are the substrate-only controls. Lanes 2–4
and 9–11 are under maximum-nuclease
conditions, and lanes 5–7 and 12–14 are
under maximum-helicase conditions.
Schematic representations of the sub-
strate structures are depicted on the top
of the gel, and a nucleotide length marker
series is indicated at the left side of the
gel. The numbers of the nucleotides in the
flap and numbers of the base pairs in
the duplex regions are labeled. Percent
product formation is indicated at the bot-
tom of the gel. B, the experimental de-
signs are the same as in A. Lanes 1–8
contain a 3-radiolabeled 38-nucleotide
double flap substrate (D1:T1:U1), and
lanes 9–16 are the substrates with a 2-
branch point at the 12th nucleotide from
the 5-end of the flap. Lanes 1 and 8 are
the substrate-only controls, and lanes 2
and 10 are the FEN1-only controls. Lanes
3–5 and 11–13 are under maximum-nu-
clease conditions, and lanes 6–8 and
14–16 are under maximum-helicase
conditions. N, maximum-nuclease; H,
maximum-helicase.
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The Tracking Requirement of Dna2p Should Protect Replica-
tion Intermediates—Dna2p is a single strand DNA-specific en-
donuclease, and there have been reports indicating that it
cleaves internally on a stretch of single-stranded DNA or a
single-stranded circular plasmid, although this activity is weak
(22, 23, 26). This internal binding property would allow Dna2p
to bypass the tracking mechanism and potentially cleave the
single-stranded regions between Okazaki fragments. To exam-
ine possible accessing of substrate without tracking, we de-
signed different lengths of gap substrates flanked by two prim-
ers, and we tested Dna2p cleavage on these substrates under
both maximum-nuclease and maximum-helicase conditions
and in the presence and absence of RPA (Fig. 5). Contrary to
previous results, we found that Dna2p is not able to cleave
single-stranded DNA internally (Fig. 5, lanes 6–10 and 16–20).
The gaps of either 29 or 70 nucleotides are not cleaved, whereas
the control substrates with flaps either 30 or 73 nucleotides
long continue to exhibit characteristic cleavage patterns by
Dna2p (Fig. 5, lanes 1–5 and 11–15). RPA did not allow Dna2p
to enter the substrate without a free single-stranded end (Fig.
5, lanes 8, 10, 18, and 20), suggesting that the RPA-mediated
stimulation mechanism does not bypass tracking (31). The
presence of RPA sometimes alters the cleavage patterns by
Dna2p (Fig. 5, compare lane 2 to 3, lane 12 to 13, and lane 14
to 15), as observed previously (10). We postulate that as with
FEN1 (14), the tracking requirement of Dna2p is designed to
prevent the nuclease from accessing the replication intermedi-
ates that may cause double strand breaks during replication.
DISCUSSION
Removal of the RNA primers of Okazaki fragments requires
formation and cleavage of 5 single-stranded flaps. At least
some of these are expected to become sufficiently long to re-
quire the sequential nuclease actions of Dna2p and FEN1 (6, 8,
10). Considerable evidence supports a mechanism by which
FEN1 enters the flap at its 5-end and then tracks to the base
of the flap for cleavage (14, 19, 32). The nuclease and helicase
activities of Dna2p have been reported to prefer substrates
containing 5-ends (25, 26). These observations suggested to us
that Dna2p is also a tracking enzyme. Here we have analyzed
cleavage specificity of Dna2p by using substrates designed to
define its tracking characteristics. Results of our analyses uni-
formly support the conclusion that Dna2p nuclease moves for
cleavage by a tracking mechanism similar to that of FEN1.
This mechanism is not influenced substantially by the presence
of helicase activity.
Dna2p is a helicase with conserved helicase motifs and
shows evidence of effective ATP hydrolysis when ssDNA and
ATP are both present (25). Under all the conditions tested, the
helicase activity is most active when ATP is present in excess
over MgCl2 (10). In fact, the helicase function of Dna2p is
essential (9), and the deficient mutant only grows on media
containing galactose that supports slow growth (33). However,
the helicase function is not robust, and it is not known whether
its essential property is manifested in Okazaki fragment proc-
essing. Previous studies have shown that the helicase activity
aids the processing of initiator primers on long flaps (10, 25).
However, our coupled nuclease-helicase assays indicate that
the helicase is not effective enough to move down the flap to its
base and then displace the annealed regions.
Most DNA helicases bind single-stranded DNA internally
and then exhibit ATP-driven motion on that strand, dissociat-
ing adjacent annealed strands. Blocking primers on the 5
FIG. 5. The tracking mechanism prevents Dna2p from cleaving replication intermediates. A reaction with Dna2p (100 fmol) and RPA
(100 fmol) was performed under maximum-nuclease (lanes 2–3, 7–8, 12–13, and 17–18) or maximum-helicase (lanes 4–5, 9–10, 14–15, and 19–20)
conditions, as described under “Experimental Procedures.” A 3-radiolabeled 30-nucleotide (D7:T6:U3) and a 3-radiolabeled 73-nucleotide (D3:T3:
U1) double flap control reactions were done in lanes 1–5 and 11–15, respectively. A 5-radiolabeled 29-nucleotide (D8:T7:U4) and a 5-radiolabeled
70-nucleotide (D9:T8:U5) gap substrates mimicking replication intermediates were tested in lanes 6–10 and 16–20. Lanes 1, 6, 11, and 16 are the
substrate-only controls. Schematic representations of the substrate structures are depicted on the top of the gel, and a nucleotide length marker
series is indicated at the left side of the gel. The numbers of the nucleotides in the flap and numbers of the base pairs in the duplex regions are
labeled. Percent product formation is indicated at the bottom of the gel. N, maximum-nuclease; H, maximum-helicase.
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terminus of the flap substrates were able to inhibit Dna2p
cleavage even though a long gap was presented to Dna2p,
which would create enough space for the enzyme to bind di-
rectly from the solution (Fig. 3A). Bubble substrates also pre-
vent Dna2p cleavage because the 5-end of the flap is annealed
to the template (Fig. 2B). These results show that cleavage by
Dna2p requires entry from the 5 terminus of DNA, not typical
of other helicases.
Previously, it was shown that Dna2 nuclease could cleave a
single-stranded circular substrate, indicating internal binding
(23). However, evidence suggests that this mode of cleavage is
not biologically relevant. It is inhibited by the presence of RPA
when tested on a single-stranded DNA with flanking double-
stranded regions (22). Studies of helicase function of Dna2p
revealed that binding is greatly favored on substrates with free
5-ends because the enzyme could use the 5-end as an efficient
entry point. When the enzyme was given the choice of unwind-
ing a primer by binding the adjacent single-stranded region
internally or entering from the end, the enzyme preferred the
DNA end (25).
In all the substrates we tested here, we observed an end
requirement for Dna2p cleavage. Unlike results reported pre-
viously (22, 26), we did not observe internal cleavages with
single-stranded regions flanked by primers (Fig. 5) in the pres-
ence or absence of RPA. We suspect that in vivo Dna2p had
evolved to require end entry for the same reason proposed for
FEN1 (14). Numerous single-stranded regions are exposed dur-
ing replication, which, if cleaved, would make double strand
breaks in the chromosome. Production of a number of double
strand breaks that are not repaired will eventually lead to cell
cycle arrest (34).
Results with primers or biotin-streptavidin conjugations
placed centrally on a long flap reveal that Dna2p does not
employ a looping mechanism, in which binding the 5 terminus
activates the protein for second-site binding internal to the
single strand (Fig. 3). The tracking process appears to require
protein movement down the strand. Additional results show
that Dna2p could track over a biotinylated substrate, and a
substrate in which one nucleotide was substituted with 3-ami-
no-thiocyano-1,2-propanediol (Figs. 3B and 4A). This means
that movement does not require the contact with a series of
adjacent unmodified nucleotides. In this way, it is different
from replicative DNA polymerase movement on DNA tem-
plates, which is inhibited by damaged nucleotides. Most heli-
cases, upon encountering a damaged nucleotide, might be ex-
pected to dissociate. Indeed, a benzo[a]pyrene-DNA adduct
inhibits the translocation activity of a helicase encoded by gene
4 in bacteriophage T7 (35). A recent study with the human
Werner syndrome helicase, a RecQ helicase, and benzo[c-
]phenanthrene diol epoxide dA adducts also revealed that these
helicases are affected by the strand, orientation, and stereo-
chemistry of the adducts (36). However, because of the 5-entry
requirement, Dna2p must be able to traverse the site without
dissociation.
The tracking function may be only partly related to the
helicase. A 5-end requirement is observed not only under
conditions favoring the nuclease, but even when ATP is totally
absent from the reaction (data not shown). Unlike FEN1,
Dna2p is able to cleave after a branched point on a modified
flap (Fig. 4B), indicating that the strand must fit through a
limited sized chamber in the enzyme. This suggests that the
tracking process involves an actual threading of the strand
through the protein. Whether or not the strand is fully encir-
cled awaits evidence from future crystallographic analyses.
The inhibition of Dna2p cleavage by the prokaryotic SSB is
also consistent with a requirement for tracking (21) (data not
shown). SSB is expected to block Dna2p movement on the flap
and could also be blocking access to the DNA for cleavage.
Inhibition by SSB contrasts with the stimulatory effect of RPA,
which must facilitate tracking, cleavage, or both. It is difficult
to envision how bound RPA could facilitate threading move-
ment or even allow access for cleavage. It was reported that
RPA and Dna2p interact with each other by specific protein-
protein contacts via their C termini (31). The fact that Dna2p
and RPA interaction requires the formation of a ternary com-
plex with single-stranded DNA and that it affects catalysis
raises the possibility that RPA binding to DNA allows the
direct recruiting of Dna2p to the site of cleavage, bypassing the
rate-limiting tracking step (21). Our preliminary results do not
favor this mechanism (Fig. 5); however, further study is
needed. Interaction of Dna2p and RPA in the presence of var-
ious substrates, using both catalytic and binding assays, should
be analyzed. Future detailed examinations of RPA effects on
both the helicase and ATPase activities of Dna2p will permit
more understanding of the underlying mechanisms of this in-
teraction. Analysis of the interaction of the two proteins by
structural approaches will also reveal valuable information on
the functions of this protein-protein contact. The very fact that
the stimulation was not anticipated, based on the expected
inhibitory effect of bound protein, suggests that it is biologi-
cally relevant.
RPA-coated flaps are inhibitory to FEN1 tracking (21). The
specific stimulation of RPA on Dna2p and the inhibition by
RPA of FEN1 tracking and cleavage led to the conclusion that
RPA orders the actions of the two nucleases during long flap
processing (6, 10, 21).
Overall, our results led us to propose a novel mechanistic
model for Dna2p cleavage. Dna2p, like FEN1, will recognize
the 5-end of a flap and track along the single-stranded region
prior to cleavage. We summarize the properties of the two
tracking enzymes participating in DNA replication below (14,
19, 32). The tracking properties of both nucleases are similar
except that Dna2p may employ a threading-like mechanism,
whereas FEN1 does not. As suggested before, Dna2p prefers
long flaps, especially when they are coated by RPA, whereas
FEN1 prefers short flaps as its substrates (6, 10, 21, 23). Only
FEN1 can cut at the base of a flap in one cleavage reaction to
create the substrate for DNA ligase, although multiple Dna2p
cleavages on one substrate may achieve similar results in vitro
(6, 21). This property also supports the proposed order of action
for the two nucleases (10, 21).
The nuclease activity of FEN1 alone has been proposed to be
sufficient for processing most of the flaps in Okazaki fragment
maturation (6, 10). Unprocessed flaps are the intermediates
leading to recombination and repeat sequence expansion (37–
40). The null mutant of FEN1 in S. cerevisiae, rad27, exhibits
a hyper-recombinogenic phenotype and a many-fold increase in
genomic instability (29), whereas dna2-1 mutants only show
2–3-fold increase in both dinucleotide instability and trinucle-
otide fragility (CAG-155 tract) (41, 42). This indirectly reveals
that FEN1 has a broader role in processing flaps than Dna2p
during replication.
Structure-containing flaps inhibit both Dna2p and FEN1
cleavages (10, 20). An exception is a flap with a foldback, also
with an unstructured 5-end region, which allows Dna2p access
under conditions in which the helicase is active (10, 25). This
suggests that Dna2p may be designed to process only a subset
of structured flaps. Other factors may be involved to work with
Dna2p to process most of the structured flaps (10, 22). Possible
candidates are Rrm3p, Pif1p, and Sgs1p, the yeast counterpart
of BLM and WRN (43–45).
The tracking mechanism of Dna2p may also have other roles
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in cellular DNA metabolism, because processing of Okazaki
fragments may be only one of many biological functions of
Dna2p (6, 10). The essential nature of Dna2p in DNA metabo-
lism is under intensive study. Many studies have revealed that
it may be part of the double strand break repair pathway or
ribosomal DNA and telomere replication (44, 46, 47). Clearly,
further study of the interaction of Dna2p with other proteins
for cleavage of long flaps is necessary just to understand its role
in DNA replication.
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